Skip to main content
Screener/Healthcare/Biotechnology

PTGX — Protagonist Therapeutics, Inc.

NASDAQ
$117.89+2.86 (+2.49%)
Mid CapHealthcareHigh Beta
$49.38
$116.57
$114.56
$119.85
EPS (TTM)$-1.81
P/E Ratio-49.44
Dividend Yield—
Market Cap$7.17B
Volume343K
Prev Close$115.03
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0$3.8M$0.05——
Q4 '25$7.4M-$44.4M$-0.6994.9%-596.8%
Q3 '25$4.7M-$39.3M$-0.62100.0%-834.9%
Q2 '25$5.5M-$34.8M$-0.55100.0%-627.0%
Q1 '25$28.3M-$11.7M$-0.19100.0%-41.2%
Q4 '24$170.6M$131.7M$1.98100.0%77.2%
Q3 '24$4.7M-$33.2M$-0.54100.0%-710.4%
Q2 '24$4.2M-$30.6M$-0.50100.0%-734.7%
Get Your Daily Market Recap